The Bridge: The Life and Rise of Barack Obama

Bridge to Life Ltd. Names New Chief Financial Officer and Vice-President of Operations

Retrieved on: 
Thursday, January 26, 2023
Eastman Kodak Co v. Harold Worden, Wharton School of the University of Pennsylvania, University, INSEAD, MBA, CFO, IQVIA, Thermo Fisher Scientific, SynCardia Systems, Ecologically based invasive plant management, BD, Fullerton Health Group, The Bridge: The Life and Rise of Barack Obama, Women's health, BS, Management, Economics, Operation

Bob Beechey possesses extensive experience in the life sciences sector, having held senior executive posts at both publicly traded and privately held companies.

Key Points: 
  • Bob Beechey possesses extensive experience in the life sciences sector, having held senior executive posts at both publicly traded and privately held companies.
  • His distinguished track record includes CFO titles at Aspira Women's Health, Quintiles Transnational Corporation, Thermo Fisher Scientific, and Eastman Kodak's Health Group.
  • Blago Herrera brings over three decades of experience in the manufacturing and supply chain operations med tech sector.
  • Adding their experience and expertise to our executive leadership team is the logical next step as Bridge to Life plans to become the global leader in organ preservation."

Bridge to Life Ltd. Announces the Appointment of Bob Beechey as Chief Financial Officer and Blago Herrera as Vice-President of Operations

Retrieved on: 
Wednesday, January 11, 2023
Thermo Fisher Scientific, Ecologically based invasive plant management, Wharton School of the University of Pennsylvania, SynCardia Systems, INSEAD, Women's health, CFO, Herrera, MBA, BS, Growth, The Bridge: The Life and Rise of Barack Obama, IQVIA, University, BD, Eastman Kodak Co v. Harold Worden, Management, Operation, Economics

NORTHBROOK, Ill., Jan. 11, 2023 /PRNewswire/ -- Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion technologies, announced the appointment of Bob Beechey as Chief Financial Officer and Blago Herrera as Vice President of Operations.

Key Points: 
  • NORTHBROOK, Ill., Jan. 11, 2023 /PRNewswire/ -- Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion technologies, announced the appointment of Bob Beechey as Chief Financial Officer and Blago Herrera as Vice President of Operations.
  • Bob Beechey possesses extensive experience in the life sciences sector, having held senior executive posts at both publicly traded and privately held companies of varying size.
  • His distinguished track record includes CFO titles at Aspira Women's Health, Quintiles Transnational Corporation, Thermo Fisher Scientific, Eastman Kodak's health group, and Arthur Andersen.
  • Beechy earned his MBA from INSEAD and holds a BS in Economics from the esteemed Wharton School of the University of Pennsylvania.

The Donate Life Community and its Inspiring “Lifting Each Other Up” Float Invites Audiences to Watch the 2023 Rose Parade January 2

Retrieved on: 
Friday, December 30, 2022
Events, Concerts, Surgery, General Entertainment, Optical, General Health, Philanthropy, Fund Raising, Foundation, Family, Science, Entertainment, Other Philanthropy, Consumer, Other Science, Health, Dignity, Thermo Fisher Scientific, Cedars-Sinai Medical Center, NBC, Medicine, Service Corporation International, Public sector banks in India, CompuMe, Rose, American Association of Tissue Banks, Walkers, Gift, Eye, KTLA, Donate Life America, Transplant, ABC, Gift of Life Marrow Registry, Rural Free Delivery, Tree, Univision, The Bridge: The Life and Rise of Barack Obama, Hospital, Medical device, Peafowl, LifeSharers

On January 2, 2023, the Donate Life community will celebrate 20 years of participation in the Rose Parade® as its inspiring “Lifting Each Other Up,” float makes its way down Colorado Blvd.

Key Points: 
  • On January 2, 2023, the Donate Life community will celebrate 20 years of participation in the Rose Parade® as its inspiring “Lifting Each Other Up,” float makes its way down Colorado Blvd.
  • The 134th annual parade kicks off at 8:00 a.m. PT (11:00 a.m.
  • ET) and it will air on ABC, KTLA 5, NBC, Univision, Peacock, Cowboy Channel, and RFD-TV — or Rural Free Delivery.
  • The centerpiece of the 2023 Donate Life float is a spectacular street dragon which in Asian cultures symbolizes great power, good luck and strength.

Celebrating 20 Years of Rose Parade Participation, The 2023 Donate Life Rose Parade® Float, Lifting Each Other Up Will Honor 59 Organ, Eye and Tissue Donors and Recipients

Retrieved on: 
Tuesday, December 27, 2022
Other Consumer, Surgery, Entertainment, Philanthropy, Events, Concerts, General Entertainment, General Health, Consumer, Health, Foundation, Dignity, Thermo Fisher Scientific, Eye, Multimedia, SC, Coffee, Human, Service Corporation International, AL, Public sector banks in India, Veteran, LifeSharers, CompuMe, Hospital, American Association of Tissue Banks, Walkers, B cell, Transplant, Kidney, Donate Life America, Cornea, EMT, UCLA, Urine, Travel, Patient, The Bridge: The Life and Rise of Barack Obama, Heart, OK, Life, Liver, Toy, Medical device, Tanning (leather), Dentistry, Pharmaceutical industry, Vaccine, Cultured pearl

The Donate Life community is celebrating 20 years of participation in the traditional Rose Parade in Pasadena.

Key Points: 
  • The Donate Life community is celebrating 20 years of participation in the traditional Rose Parade in Pasadena.
  • The 2023 Donate Life Rose Parade® float, “Lifting Each Other Up,” will feature 59 honorees representing 24 states in the United States.
  • View the full release here: https://www.businesswire.com/news/home/20221227005030/en/
    Celebrating 20 Years of Rose Parade Participation, The 2023 Donate Life Rose Parade® Float, Lifting Each Other Up Will Honor 59 Organ, Eye and Tissue Donors and Recipients (Graphic: Business Wire)
    The 2023 Donate Life Float will feature:
    39 floragraphs (floral portraits) representing organ, eye and tissue donors who gave the gift of life to others
    Four honorees whose lives were connected to organ donation will walk alongside the 2023 Donate Life float.
  • These donors gave the ultimate gift of life to save and heal others through the power of organ, eye and tissue donation.

South Carolina Donors Honored During 134th Donate Life Rose Parade

Retrieved on: 
Thursday, January 5, 2023
Lifting, Friends, Health, Birth certificate, SHSC, Hope, SC, The Bridge: The Life and Rise of Barack Obama, Ellenberg, Motor vehicle, Eye, Parent, Rose Parade, Donate Life America, Entertainment, Toy, Pharmaceutical industry

CHARLESTON, S.C., Jan. 5, 2023 /PRNewswire/ -- We Are Sharing Hope SC (SHSC), Bridge to Life, Donate Life South Carolina, Global Transplant Solutions, Inc., and the South Carolina Department of Motor Vehicles participated in the 134th Rose Parade in Pasadena, California.

Key Points: 
  • CHARLESTON, S.C., Jan. 5, 2023 /PRNewswire/ -- We Are Sharing Hope SC (SHSC), Bridge to Life, Donate Life South Carolina, Global Transplant Solutions, Inc., and the South Carolina Department of Motor Vehicles participated in the 134th Rose Parade in Pasadena, California.
  • The South Carolina based groups honored the Ellenberg family and others as the Donate Life Rose Parade® float travelled down Colorado Blvd, with the mission of inspiring others to be a registered donor.
  • "The message of lifting each other up is essential in this year's participation in the Donate Life Rose Parade float," said Tracy Moore, CEO of Donate Life South Carolina.
  • Bridge to Life, a global provider of medical devices with operations in Columbia, South Carolina, has worked closely with the Rose Parade and the Donate Life float, sending families to Pasadena impacted by organ donation since 2010.

DaVita's Move It with Purpose Event Raises Funds for Bridge of Life

Retrieved on: 
Tuesday, December 20, 2022
AmerisourceBergen, Quality of life, PD, The Bridge: The Life and Rise of Barack Obama, Wilmer Cutler Pickering Hale and Dorr, Family, Patient, Education, NYSE, Dialysis, NxStage, Community, Fresenius Medical Care, Transplant, Chronic kidney disease, Wells Fargo, Kidney disease, Gary Doer, Kidney, Diabetes, BOL, Philippine Council of Evangelical Churches, Friends, DaVita Inc., Gardening, Medical missions, Therapy, DVA, Peritoneal dialysis, Hypertension, World Wide Technology, Baxter, Physician, Conditional sentence, Yoga, Pharmaceutical industry, Health insurance, Medicine

DENVER, Dec. 20, 2022 /PRNewswire/ -- Today, DaVita announced that over 4,400 DaVita teammates, friends, family and key members of the kidney care community joined together to participate in the inaugural Move It with Purpose (MIWP) event to benefit Bridge of Life, a nonprofit founded by DaVita to support the prevention and treatment of chronic disease.

Key Points: 
  • The event has raised nearly $15 million for the nonprofit since 2007, enabling Bridge of Life to enhance kidney care globally through its medical missions.
  • "Bridge of Life is thrilled to be the recipient of so much generosity and goodwill thanks to DaVita, event sponsors and participants," said Lori Vaclavik, executive director for Bridge of Life.
  • For every mile logged on the MIWP site, DaVita donated $1 to Bridge of Life, up to $250,000.
  • Bridge of Life has assisted more than 130,000 people in underserved communities since its first mission in 2006.

Bridge to Life Ltd. Names Don Webber as President and CEO

Retrieved on: 
Thursday, October 20, 2022
Lung, State University of New York, Sale, Science, LLC, Air force, NASDAQ, Patient, United, Webber, MBA, Nova Southeastern University, SynCardia Systems, Kidney, The Bridge: The Life and Rise of Barack Obama, Board, CEO, Liver, Safety, State university system, Perfusion, Heart, Industrial technology, Surgeon, Retirement, Management, Life

NORTHBROOK, Ill., Oct. 20, 2022 /PRNewswire/ -- The Board of Directors for Bridge to Life, a world leader in organ preservation, announced Don Webber as the new President and Chief Executive Officer. Webber's appointment comes after Steve Schweighardt, founder, and former CEO for over seventeen years, announced his retirement from daily operations. Schweighardt will remain as Chairman. 

Key Points: 
  • NORTHBROOK, Ill., Oct. 20, 2022 /PRNewswire/ -- The Board of Directors for Bridge to Life, a world leader in organ preservation, announced Don Webber as the new President and Chief Executive Officer.
  • In making the announcement, Schweighardt stated, "We are very pleased to announce that Don will be taking over as President and CEO effective immediately.
  • Webber brings over 30 years of executive leadership experience to Bridge to Life and has extensive experience developing and commercializing medical products.
  • Prior to joining Bridge to Life, Webber served as CEO of SynCardia Systems, LLC, and was responsible for the turnaround and successful sale of the company.

DaVita Celebrates 2021 ESG, Corporate Social Responsibility Achievements

Retrieved on: 
Tuesday, May 3, 2022
COVID-19, Integrity, Woman, American Diabetes Association, Patient, DaVita Inc., Color, Science, Compliance, The Bridge: The Life and Rise of Barack Obama, Ethics, Dialysis, Conditional sentence, Vaccine, Mark (given name), Vaccination, Goal, HOPE, CEO, ESG, Lithium, Pharmaceutical industry, Nightclub, Medicine, Renewable energy

DENVER, May 3, 2022 /PRNewswire/ -- Today, DaVita Inc. highlighted its continued commitment to corporate citizenship with the publication of its annual Community Care Environmental Social Governance (ESG) Report.

Key Points: 
  • "I'm humbled reflecting on the incredible and intentional contributions of our teammates to better the world around them," says Javier Rodriguez, CEO of DaVita.
  • "At DaVita, we strive to make a lasting, positive impact on health care and the lives we touch along the way.
  • 84% of teammates feel a sense of belonging within the DaVita community based on our 2021 survey.
  • More than $910,000 was raised by the Tour DaVita event to benefit Bridge of Life, a nonprofit founded by DaVita with international programs supporting the prevention and treatment of chronic diseases.

Bridge to Life Ltd. Receives Breakthrough Device Designation from the FDA

Retrieved on: 
Thursday, April 21, 2022
CEO, Kidney, Workflow, The Bridge: The Life and Rise of Barack Obama, Regulation of tobacco by the U.S. Food and Drug Administration, Research, Transport, Food, Science, Organization, Perfusion, Lung, Surgeon, Technology, Heart, Solution, Transplant, Business development, FDA, Liver, Medical device, Dietary supplement, Life, Bridge

NORTHBROOK, Ill., April 21, 2022 /PRNewswire/ -- Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion technologies, announced breakthrough device designation authorization by the U.S. Food and Drug Administration (FDA) for its LifeCradle® Heart Preservation Transport System.

Key Points: 
  • Bridge to Life advances their perfusion system development with the breakthrough device designation for the LifeCradle Heart Preservation Transport System.
  • NORTHBROOK, Ill., April 21, 2022 /PRNewswire/ -- Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion technologies, announced breakthrough device designation authorization by the U.S. Food and Drug Administration (FDA) for its LifeCradle Heart Preservation Transport System.
  • TheLifeCradle Heart Preservation Transport System provides clinicians with the ability to affordably implement hypothermic oxygenatedperfusion of heart grafts during graft transport from the donor site to thetransplantcenteroperatingroom.
  • "Bridge to Life continues to research and develop technology to improve organ preservation and have now added organ perfusion devices including for liver, kidney, lung and heart to our portfolio of products," said Bridge to Life Chairman and CEO StevanSchweighardt.

Bridge to Life Ltd. Announces First Enrollment and Orthotopic Liver Transplantation in its Pivotal Bridge to HOPE Liver Clinical Trial

Retrieved on: 
Wednesday, February 2, 2022
Liver kidney microsomal type 1 antibody, Pancreas, Perfusion, Principal investigator, Drexel University, Patient, MI, Organization, Clinical trial, The Bridge: The Life and Rise of Barack Obama, Transplant, Technology, Henry Ford, Research, Partnership, Oxygen, Liver, Surgeon, Science, Heart, Transplant surgeon, HOPE, VP, General surgery, Organ transplantation, Business development, Lung, History, Solution, Hospital, Dentistry, MD, Atlantic Ocean, Life, Bridge, Kidney

NORTHBROOK, Ill., Feb. 2, 2022 /PRNewswire/ -- Bridge to Life Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion technologies, announced first enrollment and orthotopic liver transplantation in its U.S. pivotal Bridge to HOPE Liver Clinical Trial (NCT05045794).

Key Points: 
  • NORTHBROOK, Ill., Feb. 2, 2022 /PRNewswire/ -- Bridge to Life Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion technologies, announced first enrollment and orthotopic liver transplantation in its U.S. pivotal Bridge to HOPE Liver Clinical Trial (NCT05045794).
  • The trial is anticipated to enroll up to 244 patients undergoing transplantation at up to 15 hospitals over the next 2 years.
  • "We are very grateful for the partnership we have established with the Bridge to Life team.
  • "We celebrate this pivotal study milestone, thrilled with how well the inaugural Bridge to HOPE perfusion went.